Government Private

DOH-retained
EC
LGU
Pvt Hospitals
GOV'T Institution Retail
H.A/DS/DISP

Qualifirst Health, Inc

Sales Report as of DEC 2012
Data per Fieldman
INTERNAL MONITORING

ACCOUNTS

CHANNEL

106,600,000.00

TOTAL
EXTERNAL AFFAIR
FAMILY VAC. & SPECIALTY CLINIC
UNILAB
CORPORATE PRODUCT BOARD
UNITED BAYANIHAN FOUNDATION
HEALTHDEV INTEGRATED CL. INC
GB DIST. (GB ISOPHARMA)
ZALDY VARGAS
PIGUERRA, MARLYN
GAWWA FOUNDATION
GB FORWARDER
MS.KARLA DE LA ROSA C/O SARAH ALCOBER
WATSONS
WATSONS (CONS.)
APOLLOPLUS
MR.RICHARD DY
MACANDILI
HOUSE ACCOUNTS

Annual
Sales Budget

H.A
H.A
H.A
H.A
H.A
H.A
H.A
H.A
H.A
H.A
H.A
H.A
RETAIL
RETAIL
RETAIL
H.A
H.A
1,000,000.00

JAN-DEC
BUDGET
106,600,000.00
1,000,000.00

JAN

FEB

2,153,718.47

3,701,900.22

MARCH

5,152,414.05

3,737.50

38,844.38

47,441.63

212,319.29
544,170.68

86,286.01

212,319.29

547,908.18

1ST QTR
SALES
11,008,032.74
3,737.50
38,844.38
259,760.92
544,170.68
846,513.48

APRIL

MAY

3,301,420.49

2,580,716.04

25,152.33

51,115.10

20,785.71

46,764.37

45,938.04

97,879.47

ACCOUNTS

CHANNEL

Annual
Sales Budget
39,424,000.00

TEAM 1 (FELIX SISON)

PGH-1
RITM
ICTSI
SOUTH STAR
DAISY,TIGA
COMPLETE SOLUTION
SAN LORENZO RUIZ WOMEN'S
DEPARTMENT OF HEALTH (MANILA)
LAS PIAS GEN. HOSP.
ST.DOM
TONDO MEDICAL CENTER
CENTRALLE BOTICA
OLIVARES
DR. JOSE N. RODRIGUEZ MEM.
VALENZUELA MED. CENTER
VETERANS MEM. MED. CTR.
B.Trinidad

DOH-RETAINED
DOH-RETAINED
PVT. HOSP.
RETAIL
PVT. HOSP.
RETAIL
DOH-RETAINED
DOH-RETAINED
DOH-RETAINED
PVT. HOSP.
DOH-RETAINED
EC
EC
DOH-RETAINED
DOH-RETAINED
DOH-RETAINED

PHIL. TUBERCULOSIS SOCIETY

PGH-II
AIER
EAST AVE. MED. CTR
NATIONAL CHILDREN HOSPITAL
POC
ICTSI
THE FAMILY CLINIC
STA.TERESITA
CEBER
HON. JOSE MARIO DON S. DE LEON
OUR LADY OF GRACE
J. Formantes

DOH-RETAINED
DOH-RETAINED
EC
DOH-RETAINED
DOH-RETAINED
DOH-RETAINED
GOV'T-INS.
PVT. HOSP.
PVT. HOSP.
EC
GOV'T-INS.
PVT. HOSP.

FAR NORTH
MARIANO MARCOS
ENZAPP
NAVARETTE
QUINCEY'S
MRP
METRO VIGAN COOP
SABI NI DOC
SV PHARMA
ABM-A BUILDER MARKETING
STEFANS
BENJO'S PHARMA
HALOGS
ROLBIS
BOTIKA TI PROBINSYA TI
LAOAG CITY GEN HOSP.
ILOCANDIA HEALTHLINK CLINIC
PIRA HOSPITAL
PROVINCE OF LA UNION
VIGAN MAHARLIKA
CAYETANO PHARMA

DOH-RETAINED
DOH-RETAINED
RETAIL
DS
DS
EC
DS
DS
EC
DS
EC
DS
DS
EC
LGU
LGU
PVT. INS.
PVT. HOSP.
LGU
PVT. HOSP.
EC

5,896,000.00

8,008,000.00

JAN-DEC
BUDGET
39,424,000.00
5,896,000.00
8,008,000.00
-

JAN

FEB

1,090,120.45

1,299,239.99

25,875.00
541.87

51,696.43
(541.87)

MARCH
2,544,304.65
301,883.93

2,464.29

81,691.97
108,108.84

12,133.93
88,571.42
193,705.36
348,029.56

17,799.11
5,142.86
(17,714.29)
63,750.00

68,977.68

58,080.36
249,107.14
160,801.79
2,053.57

20,625.00
28,125.00
146,116.07
496,750.00
10,679.46
409,024.10
128,719.47
289,053.57
12,451.70

13,129.36

37,015.52

483,172.22

886,943.82

98,503.57

132,931.03
167,376.80

213,493.44
11,250.00
16,723.22
11,049.10
(2,049.24)
2,049.24

5,873.79
42,300.00
5,156.25
1,862.95
3,622.50

12,500.00
23,656.08

10,969.64
4,296.22

4,117.14

8,007.71

11,592.00

1ST QTR
SALES
4,933,665.09
379,455.36
2,464.29
32,758.93
198,388.39
339,821.43
952,888.40
28,478.57
414,166.96
186,799.83
520,446.42
237,003.49
2,053.57
50,144.88
1,439,093.72
346,424.47
265,880.37
11,250.00
16,723.22
11,049.10
10,450.76
25,705.32
5,873.79
53,269.64
5,156.25
10,276.31
23,222.21
-

APRIL

MAY

999,789.62

1,278,117.05

83,303.57

88,875.00

67,250.00

66,241.07
58,125.00
213,241.07

150,553.57
7,119.64
37,657.14

17,799.11
31,875.00
5,428.57

175.00

1,492.86

6,629.46

(6,629.46)

51,581.24

49,966.08

177,686.71
-36000.01

70,939.92

9,723.21

134,553.30

1,839.37
237,677.13

7,245.00

6,160.71

ACCOUNTS

CHANNEL

E.Talosa

Annual
Sales Budget
7,480,000.00

ERLN
MANSON DRUG
GERPHS
HEALTH SCIENCE
MUNICIPALITY OF BACOLOR
MUNICIPALITY OF LUBAO
LAZAR PHARMA/JENIGE
CENTER FOR HEALTH DEV'T REGION III
SANVEN
QUALIZEN
PROVINCE OF PAMPANGA
PROVINCE OF BATAAN
F2 PHARMACY
SARILING ATIN/ MACROMARK
JOSE B. LINGAD
V.TIERRA

EC
RETAIL
EC
EC
LGU
LGU
EC
GOV'T-INS.
EC
DS
LGU
LGU
EC
EC
DOH-RETAINED

ADVENTA
FARMACIA NAVALTA
DR. PAULINO
BAGUIO GEN.
BENGUET GEN. HOSPITAL
ILOCOS TRAINING
JPMR
A.Timbre

EC
DS
DOH-RETAINED
DOH-RETAINED
LGU
DOH-RETAINED
EC

10,208,000.00

7,832,000.00

JAN-DEC
BUDGET
7,480,000.00
10,208,000.00
7,832,000.00

JAN
300,282.15

FEB
156,482.32

MARCH
328,516.97

8,928.57

23,214.29
258,741.08

524,225.88

13,227.50

22,075.89

(46,000.01)
510,368.73

13,227.50

38,062.62
318,879.59

(76,964.28)

(15,178.57)

158,035.71

88,392.86

122,321.43

27,857.14
273,749.99

61,026.79
29,927.68
102,383.05

49,910.71
141,274.82
298,328.39

53,571.43
513,214.27

1ST QTR
SALES

APRIL

MAY

785,281.44
8,928.57
23,214.29
258,741.08
-

293,208.21

316,617.13

135,407.13
10,294.64

71,208.22
(5,351.79)

559,529.27
(7,937.39)
842,475.82
65,892.86
27,857.14
484,464.28
110,937.50
224,773.93
913,925.71

38,878.75

35,140.19

184,580.52

64,732.14
165,728.76

66,964.29

183,035.71

17,678.57
112,053.57
16,026.79

269,642.85
6,464.28

107,142.86
319,866.08

73,421.17
532,564.01

ACCOUNTS

CHANNEL

TEAM 2 (BRYAN TRINIDAD)

Annual
Sales Budget
16,368,000.00

PNP
PNP HEALTH SERVICE
RMC (BID.)
RMC (CONS.)
PCMC
LUNG CENTER OF THE PHIL.
CAMP GEN. EMILIO AGUINALDO
RCW GEN.
BOTICA NAVAL
METRO RIZAL
AMANG (CONS)
AMANG (BIDDING)
ST.IGNATIUS
SALVE REGINA
HALCION HEALTH CENTER
PHARMA QUEST
PHARMA & HEALTHCARE
ROTARY CLUB RIVERCITY MARIKINA
MANILA EAST MEDICAL CENTER
NATIONAL KIDNEY & TRANSPLANT
QMMC (BID)
QMMC (CONS.)
ST.MONICA
ECILA PHARMA
M. Urbina

GOV'T-INS.
GOV'T-INS.
DOH-RETAINED
DOH-RETAINED
DOH-RETAINED
DOH-RETAINED
GOV'T-INS.
RETAIL
PVT. HOSP.
PVT. HOSP.
DOH-RETAINED
DOH-RETAINED
PVT. HOSP.
PVT. HOSP.
EC
EC
EC
DISP
PVT. HOSP.
DOH-RETAINED
DOH-RETAINED
DOH-RETAINED
PVT. HOSP.
EC

DAVAO REGIONAL
CENTER FOR HEALTH DEV'T DAVAO REG.
COTABATO REGIONAL & MED. CTR.
BEST BUY
SEAMAN'S-DAVAO
SOUTHERN PHIL. MED.CTR
ADELLA SIERRA
ADELS SERRA (CONS.)
SWAN PHARMACY
TESCO DRUG
ASR PHARMA
77TH JIREH
FAMACIA SOUTHERN
CARAGA REGIONAL HOSPITAL
PROVINCIAL GOVT OF BUKIDNON
LGU-GENERAL SANTOS CITY
MYCHER
JB PHARMA
A.Cereliales

DOH-RETAINED
DOH-RETAINED
DOH-RETAINED
EC
PVT. HOSP.
DOH-RETAINED
DOH-RETAINED
DOH-RETAINED
EC
EC
EC
EC
EC
DOH-RETAINED
LGU
LGU
EC
EC

5,456,000.00

5,984,000.00

JAN-DEC
BUDGET
16,368,000.00
5,456,000.00
5,984,000.00

JAN
309,154.54

FEB
771,119.52

MARCH
837,339.47

27,368.51

33,318.43

32,142.86
141,964.28

241,742.61

16,895.72
421,267.59

5,892.86
11,933.39

14,620.90
81,200.70

2,274.82
98,324.28

440,857.15

(8,530.71)

6,919.64

3,412.29
10,607.14
750.00

125,000.00

72,544.65
214,609.82
287,786.33

123,388.93

589,710.23

1,917,613.53
27,368.51
89,020.51
5,892.86
11,933.39
(379.11)
128,571.43
141,964.28

55,702.08

(379.11)
96,428.57

1ST QTR
SALES

72,991.07
8,292.95

522,141.17

APRIL

MAY

408,564.14

7,368.22

28,459.03

9,857.84

31,410.72

(9,020.72)

3,472.99

68,142.86
141,964.29

25,791.75
164,645.57

440,857.15
(8,530.71)
3,412.29
10,607.14
7,669.64
197,544.65
287,600.89
296,079.28
1,235,240.33

184,036.05

142,801.41
(13,732.15)

982.14

(12,750.01)

ACCOUNTS
GOLDEN DRUG
MHARS REGIONAL
ZCMC (BID)
ZCMC (CONS.)
PROV. GOV'T OF MISAMIS ORIENTAL
SN FAIR
TANGAPA
JESCA
MARGOSA
FARMACIA MARGA
RITEGEN
NORTHERN MIN.
DR.JOSE RIZAL MEM. HOSP.
LABUAN PUBLIC HOSP.
E.R OCHOA MEM. & MATERNITY
MATONDING, SALEM
MBN TARDING
MULTIMEDIC
B.Mark

CHANNEL

Annual
Sales Budget

EC
DOH-RETAINED
DOH-RETAINED
DOH-RETAINED
LGU
EC
DS
RETAIL
DOH-RETAINED
DS
EC
DOH-RETAINED
DOH-RETAINED
LGU
DISP
DISP
EC
EC
4,928,000.00

JAN-DEC
BUDGET
4,928,000.00

JAN

FEB

MARCH

(17,061.43)
2,633.93
7,160.72

3,995.54
29,643.75

1ST QTR
SALES

APRIL

MAY

(17,061.43)
6,629.47
36,804.47
32,763.40
10,714.29
-

10,714.29
-

110,912.05

73,290.36

39,816.40

104,564.91

83,085.01

73,455.69

224,018.81
261,105.61

243,918.57

21,221.25

243,918.57

53,984.65

ACCOUNTS

CHANNEL

TEAM 3 (GIAN NAVARETTE)

Annual
Sales Budget
18,744,000.00

BERMUDEZ
NCMH
ARNAIZ
JOSE REYES MEM.
DR.JOSE FABELLA
SAN LAZARO
ACTIMED DIST. INC
PASIG CITY GEN. HOSPITAL
Vacant

PVT. HOSP.
DOH-RETAINED
PVT. HOSP.
DOH-RETAINED
DOH-RETAINED
DOH-RETAINED
EC
LGU

SOUTHERN ISABELA GEN. HOSP.

VETERANS REGIONAL HOSPITAL
ADVENTA-II
MEDIC-1
FERMA
PROVINCE OF IFUGAO
CAGAYAN VALLEY MED. CNTR
PROVINCIAL GOV'T OF CAGAYAN
CTR.HEALTH DEVT. CAGAYAN VALLEY REGION II
BANIQUED PHARMACY
PROVINCE OF NUEVA VIZCAYA
PROVIDENCIA
Vacant(Cagayan)

DOH-RETAINED
DOH-RETAINED
EC
DS
EC
LGU
DOH-RETAINED
LGU
GOV'T-INS.
DS
LGU
EC

BABY BOOMERS
GREAT R
JN CARLO
MEDFIELDS
BICOL MED. CENTER
BATANGAS REGIONAL HOSP.
BRTTH
CDJD
BOTIKA VERDE
DE FORCS
PHYSIOTEC DRUG CO.
ST. ANNE HOSPITAL
OCSAN
R. Pesa

EC
EC
EC
EC
DOH-RETAINED
DOH-RETAINED
DOH-RETAINED
EC
EC
DS
EC
PVT. HOSP.
EC

5,016,000.00

5,896,000.00

7,832,000.00

JAN-DEC
BUDGET
18,744,000.00
5,016,000.00
5,896,000.00
7,832,000.00

JAN
352,213.63

82,589.29
(9,281.69)

FEB

MARCH

382,227.43

582,215.97

3,339.29
3,981.00

14,185.46
1,872.77

(11,473.21)

61,834.39

7,320.29

167,229.62
183,287.85

1,232.14
66,071.43
28,571.43
(21,875.00)

46,875.00
(10,937.50)
49,883.93
353.57

72,767.86

23,214.29
181,857.14
(15,487.50)

21,522.33

12,946.43
100,353.57

30,392.85
51,915.18

71,875.00
127,232.14

221,517.85
132,930.80

1,625.00
6,785.71
10,312.50

(6,785.71)

9,304.24

84,821.43

217,611.38

12,964.29
(20,400.00)

(2,589.29)
274,553.57

347,012.94

1ST QTR
SALES

APRIL

1,316,657.03
85,928.58
8,884.77
1,872.77
(11,473.21)
167,229.62
252,442.53

1,198,689.28

1,232.14
112,946.43
28,571.43
(32,812.50)
71,406.26
353.57

61,982.14

43,339.28
225,036.61
316,607.14
442,020.08
(15,487.50)
1,625.00
23,276.79
(20,400.00)
94,125.67
(2,589.29)
839,177.89

MAY
634,260.84

17,302.23
631,932.15
631,932.15

153,274.99

87,523.66
104,825.89

84,375.00
(76,562.50)
105,523.33
59,263.40

5,267.86
220,524.99

10,446.43
183,045.66

110,517.86
235,714.28

216,964.29
25,853.57

50,000.00

346,232.14

53,571.43
346,389.29

ACCOUNTS

CHANNEL

TEAM 4 (PATRICK FELIZARDO)

Annual
Sales Budget
31,064,000.00

EQ PHARMACY
MOR
PCJC
RBC
THEOMEDS
PULGA
JMC DISTRIBUTOR
JMZ PHARMACY
SCHISTOSOMIASIS CONTROL & RSCH HOSP.
EASTMED PHARMA
CAMP LUKBAN STATION HOSPITAL
OLPHI CABAYOG
HEALTHBAY DIST.
EASTERN VISAYAS
LYONAISE
J. Saludaga

DS
EC
EC
EC
EC
DS
EC
DS
DOH-RETAINED
EC
GOV'T-INS.
PVT. HOSP.
EC
DOH-RETAINED
EC

JASAC
WEST VIS. STATE UNIVERSITY
WESTERN VISAYAS MED. CTR.
PROGELEN
GSG PHARMA
ZDEL PHARMA
PROVINCE OF DUMAGETE (DR. CATALINO GALLEGO)
KOIZ
PROVINCIAL GOV'T OF ANTIQUE
ILOILO PROVINCIAL
ILOILO IPMSS
Vacant(iloilo)

GOV'T-INS.
DOH-RETAINED
DOH-RETAINED
EC
EC
EC
LGU
EC
LGU
LGU
LGU

CORAZON LOCSIN
GIA-MED
PHARMA AVE. TRADELINK
ASEAN HEALTH CARE DIST.
DUBRI DIST. SYSTEM
RAMACHO-II
MT.ZION
TETRARHO
PROVINCE OF NEGROS-BID
EEDD

DOH-RETAINED
EC
EC
EC
EC
EC
EC
EC
LGU
LGU

9,592,000.00

6,864,000.00

JAN-DEC
BUDGET
31,064,000.00
9,592,000.00
6,864,000.00
-

JAN
315,943.84

FEB
1,036,993.99

27,786.22

MARCH
640,645.78

95,679.08

20,299.22
39,773.21

626,408.91

182,357.15

39,773.21

654,195.13

298,335.45

(3,571.43)
10,175.89
19,375.00

32,042.86

4,678.52
83,482.14

19,932.14
(1,410.37)
37,485.72

24,569.09

51,975.00

125,646.38

1ST QTR
SALES
1,993,583.61
123,465.30
20,299.22
848,539.27
992,303.79
(3,571.43)
46,897.27
102,857.14
19,932.14
(1,410.37)
37,485.72
202,190.47

APRIL

MAY

648,439.41

386,422.63

63,836.91

33,962.90

27,600.00
128,578.57

16,421.95

220,015.48

50,384.85

10,707.14

4,591.07

10,707.14

4,591.07

272,107.14

191,000.89

30,357.14

30,357.14

3,467.53
18,837.96
288,422.76

140,692.86

3,467.53
18,837.96
429,115.62

ACCOUNTS

CHANNEL

Vacant(Bacolod)
VSMMC
CEBU CITY PROVINCIAL
OSLOB DIST. HOSP.
ISIDRO C.KINTANAR MEM. HOSP.
CEBU GOVERNMENT
CITY GOV'T OF TAGBILARAN
FRANK & FRANZ
BYRO PHARMA
IREZEL TRADING
BEST BUY-II
CBS
ROSE PHARMACY
MEDICAL MISSION
TAGBILARAN CITY PHARMA
RAMACHO
ST.ANTHONY
T.Melven
VETERANS REGIONAL HOSPITAL

note:
Feb Adjustment
VALENZUELA MED. CTR S.i#3208
(WRONG QTY AND RECOGNIZE CM)
March Adjustment
JN
JN CM 940-941
JN SALES FOR MARCH
DE FORCS
April Adjustment
Mariano Marcos
July Adjustment
Eastern Visayas

Annual
Sales Budget
8,096,000.00

DOH-RETAINED
LGU
LGU
LGU
LGU
LGU
EC
EC
EC
EC
EC
RETAIL
PVT. HOSP.
RETAIL
EC
DOH-RETAINED
6,512,000.00
DOH-RETAINED

(12,285.71)

132,930.80
(57,622.23)
75,308.57
(20,400.00)

-36000.01

-956.46

JAN-DEC
BUDGET
8,096,000.00
6,512,000.00
-

JAN

FEB

MARCH

1ST QTR
SALES

APRIL

MAY

49,195.10

288,422.76

144,160.39

481,778.25

272,107.14

191,000.89

114,753.56

51,614.29

72,503.56

238,871.41
-

85,047.15
2,026.79

121,597.51
6,883.93
6,450.89

16,708.84
5,258.71
34,320.36
22,151.78
317,311.10
-

58,535.71

156.25

145,609.65

5,357.24
140,445.82

12,982.95

3,725.89

5,258.71
52,223.72
17,187.50
202,406.44

(17,903.36)
4,964.28
42,401.10

72,503.56

JUNE
3,481,381.72

202.58

202.58

1ST SEM
SALES
20,371,550.99
76,267.43
3,737.50
38,844.38
202.58
327,311.00
544,170.68
990,533.57

JULY

AUGUST

2,628,213.06

3,176,854.56

4,253,871.79

159,940.92
14,811.60

24,696.58

11,071.43

SEPTEMBER

185,823.95

(9,105.05)
2,276.79
14,027.23

31,895.55

3RD QTR
SALES
10,058,939.41
184,637.50
14,811.60
(9,105.05)
13,348.22
14,027.23
217,719.50

OCTOBER

4,300,361.86

NOVEMBER

2,992,515.52

DECEMBER

5,400,676.67
119,187.43

3,152.49
(81,970.54)
(65,645.00)

(147,615.54)

122,339.92

4TH QTR
SALES
12,693,554.05
119,187.43
3,152.49
(81,970.54)
(65,645.00)
(25,275.62)

YTD

43,124,044.45
380,092.36
14,811.60
(9,105.05)
13,348.22
14,027.23
3,737.50
38,844.38
202.58
3,152.49
327,311.00
462,200.14
(65,645.00)
1,182,977.45

LYTD

%GWT

53,998,762.64

-20%

258,777.45

47%
100%
-100%
-124%
-77%
100%
100%
-100%
-100%
100%
-86%
100%
-46%
100%
100%
-100%
-100%
2%

780.00
37,703.66

59,193.21
13,256.62
600.00
1,414.96
610,024.21

173,392.87
(380.89)
1,154,762.09

JUNE
1,099,918.45
60,562.50

18,428.57

2,464.29

9,821.42
63,392.85
106,250.00
260,919.63
5,300.00
172,439.38
10,857.14
83,062.50
964.29

272,623.31

17,116.97

3,314.73

35,898.22

3,622.50

1ST SEM
SALES

JULY

AUGUST

SEPTEMBER

8,311,490.21
612,196.43
18,428.57
4,928.58
42,580.35
395,272.31
504,196.43
1,577,602.67
58,697.32
656,138.48
203,085.54
603,508.92
239,635.64
2,053.57
50,144.88
1,813,264.35

1,187,471.14

1,942,177.40

2,235,890.92

115,312.50

63,937.50

185,437.50

595,051.10
246,997.33
11,250.00
16,723.22
14,363.83
10,450.76
25,705.32
9,723.21
178,164.68
290,946.77
5,156.25
10,276.31
40,250.42
-

6,693.43

113,071.43

67,602.68
31,607.14
221,215.75

119,866.07
150,089.28
333,892.85

28,125.00
150,089.28
476,723.21

4,983.75
33,740.18
4,071.43
32,611.61
65,810.72

16,960.00
378,575.89
33,214.29
263,392.86

12,459.37
147,549.11

141,217.69

692,143.04

180,919.19

135,241.50
83,041.07

252,591.89
(25,501.79)

158,467.95
10,374.11

20,910.71

20,400.00
3,314.73
6,348.49

11,049.59
44,279.30

27,931.81

5,498.29

3,411.96

99,988.39

3RD QTR
SALES
5,365,539.46
364,687.50
119,764.86
215,593.75
331,785.70
1,031,831.81
34,403.12
559,865.18
37,285.72
316,915.18
65,810.72
1,014,279.92
546,301.34
67,913.39
20,400.00
3,314.73
6,348.49
38,981.40
144,267.69
8,910.25
-

OCTOBER
2,365,822.79

NOVEMBER
1,849,569.99

DECEMBER
1,526,767.41
128,437.50

(22,683.92)

116,656.61
54,142.85

54,214.28
8,571.43
62,785.71
5,679.82
187,683.04

140,223.22
288,338.76

128,437.50

24,111.42

10,600.00

28,816.97
244,642.86

438,005.72

52,928.39

10,600.00

290,930.61
(1,026.79)

263,288.59

43,909.82

52,678.57
12,240.00
25,892.86

5,105.81
272,055.89

206,855.77

8,686.87

3,156.97

8,705.36

78,569.16

8,278.40

4TH QTR
SALES

YTD

5,742,160.19
128,437.50
(22,683.92)
116,656.61
54,142.85
54,214.28
148,794.65
479,561.97
40,391.24
187,683.04
28,816.97
244,642.86
501,534.11

19,419,189.86
1,105,321.43
(22,683.92)
138,193.43
116,656.61
54,142.85
4,928.58
42,580.35
665,080.34
984,776.78
3,088,996.45
133,491.68
1,403,686.70
240,371.26
949,241.07
550,089.22
2,053.57
50,144.88
3,329,078.38

554,219.20
42,883.03
52,678.57
12,240.00
25,892.86
83,674.97
478,911.66
20,122.24
8,705.36
-

1,695,571.64
357,793.75
11,250.00
16,723.22
20,400.00
17,678.56
16,799.25
78,383.89
21,963.21
25,892.86
300,821.05
914,126.12
5,156.25
39,308.80
48,955.78
-

LYTD
23,524,885.12
1,720,135.10
59,382.42
37,801.04
(672,578.42)
52,761.25
3,182.50
8,035.71

%GWT
-17%

1,286,205.36
2,384,947.28

-36%
-100%
-100%
-97%
-100%
-100%
1620%
100%
100%
-100%
100%
-100%
-100%
100%
100%
-23%
30%

236,620.60
2,426,999.33
1,356,102.23
2,257,056.77
602,841.96
18,119.65
41,818.04
136,792.74
17,790.62
22,342.21
2,400.00
19,375.18
7,138,259.33

-44%
-42%
-82%
-58%
-9%
-89%
-100%
-63%
-100%
-100%
-100%
-100%
-53%

637,510.98
612,095.54
299,496.08
52,016.06
77,695.10
376,661.64
70,935.23
57,323.71
125,310.36
397,767.87
107,321.44
4,642.85
49,330.35
8,928.57
165,828.88

166%
-42%
-96%
-100%
-78%
-95%
-75%
-71%
-37%
-94%
-76%
-100%
-100%
-100%
81%
100%
43%
323%
-100%
-46%
-100%

53,400.00
(3,863.40)
(159,514.28)

3,609.37
9,296.15
4,347.32
90,540.15
4,450.89

JUNE
59,952.42

7,098.99

35,306.25

42,405.24
108,928.57
23,035.71
282,232.14
49,821.43
464,017.85

1ST SEM
SALES
1,455,059.20
8,928.57
23,214.29
213,714.34
263,683.93
668,854.46
56,794.75
1,235,190.34
424,821.43
68,571.42
1,148,392.84
22,491.07
160,758.93
405,337.96
2,230,373.65

JULY
279,109.75

AUGUST
268,097.09

SEPTEMBER
289,230.45

147,321.43

240,439.48
6,294.64

143,236.39

50,750.00
297,484.12

(2,089.29)
288,468.53

4,105.80
27,321.43
64,598.21
5,803.57
49,821.43
96,793.39
248,443.83

1,090,432.65
82,751.35

3,437.50
1,176,621.50

65,044.64
13,232.14
294,531.25

359,575.89

99,164.43
112,396.57

3RD QTR
SALES
836,437.29
147,321.43
1,474,108.52
89,045.99
52,098.21
1,762,574.15
69,150.44
40,553.57
359,129.46
5,803.57
49,821.43
195,957.82
720,416.29

OCTOBER
350,703.75

888,545.22

NOVEMBER
525,809.42

623,639.85
11,913.39

DECEMBER
402,814.72

432,982.16

1,473.21
890,018.43

635,553.24

432,982.16

251,094.90

24,553.57

118,303.57

10,357.14
356,785.71

4,285.71
209,821.43

21,071.43
356,785.71
2,200.89

6,071.43
624,309.18

108,279.47
346,940.18

53,571.43
551,933.03

4TH QTR
SALES
1,279,327.89
1,945,167.23
11,913.39
1,473.21
1,958,553.83
393,952.04
35,714.28
923,392.85
2,200.89
167,922.33
1,523,182.39

YTD
3,570,824.38
8,928.57
23,214.29
361,035.77
263,683.93
3,419,275.75
769,813.84
110,366.17
4,956,318.32
887,923.91
144,839.27
2,430,915.15
30,495.53
210,580.36
769,218.11
4,473,972.33

LYTD
3,155,108.54
120,892.85
(22,073.00)
15,916.72
92,857.69
46,824.19
43,619.69
638,958.08
167,946.45
(511,783.27)
3,770,707.19
311,042.50
753,096.09
780,647.34
6,208,652.52
1,772,647.38
44,211.15
3,535.70
1,248,482.16
50,714.29
542,428.57
975,898.20
4,637,917.45

%GWT
13%
-93%
-100%
-100%
-100%
-100%
100%
100%
100%
-100%
100%
-80%
-100%
-86%
-20%
-50%
-100%
3996%
95%
100%
-61%
-21%
-4%

JUNE
488,052.65

1,751.00
22,804.61

3,837.05
96,428.57
111,607.14

236,428.37

22,636.61

101,335.72

123,972.33

1ST SEM
SALES

JULY

AUGUST
485,876.07

SEPTEMBER

2,998,266.37
34,736.73
1,751.00
150,141.99
22,390.00
3,472.99
5,892.86
15,770.44
(379.11)
293,142.86
283,928.57
111,607.14
42,687.47
965,142.94

597,061.22

659,358.86

18,750.00
87,716.58

231,963.04

520,464.83

427,125.00
(8,530.71)
26,048.90
10,607.14
8,651.78
197,544.65
287,600.89
296,079.28
101,335.72
1,346,462.65

36,964.29

20,901.78

1,806.87

62,967.51

7,022.83

99.36

25,001.79

134,465.92

9,716.51
15,066.96

77,857.14

21,875.00

91,138.39

116,071.43
141,964.29
118,147.32

5,796.43
35,986.60
4,098.22

363,782.14

442,529.46

20,901.78

5,905.09

3RD QTR
SALES

OCTOBER

1,742,296.15
62,967.51
7,122.19
159,467.71
9,716.51
208,995.53
141,964.29
231,160.71
18,750.00
840,144.45

616,647.36

59,672.94
5,796.43
35,986.60
4,098.22
363,782.14
469,336.33

33,066.97

NOVEMBER
501,387.27

DECEMBER
2,495,192.24

518,303.57
1,367.11
112,278.30

294,514.16

23,398.22

32,753.44

3,837.05

4,570.98

35,000.00

107,366.07

210,709.82

142,745.54

6,423.32
391,646.71

288,803.14

136,607.14
43,750.00
97,816.97

1,090,991.84
4,062.50
45,192.89
396,178.57

(3,311.88)

(7,740.00)
72,506.69

(416.15)

9,650.89

42,717.86

61,454.81

445,017.81

4TH QTR
SALES
3,613,226.87
518,303.57
1,367.11
406,792.46
56,151.66
8,408.03
278,973.21
43,750.00
451,272.33
6,423.32
1,771,441.69
37,129.47
45,192.89
396,178.57
(3,311.88)
(7,740.00)
72,090.54
9,650.89
549,190.48

YTD

LYTD

%GWT

8,353,789.39
62,967.51
553,040.30
10,240.30
716,402.16
78,541.66
3,472.99
5,892.86
33,894.98
(379.11)
781,111.60
469,642.86
794,040.18
67,860.79
3,576,729.08

8,238,982.20

1%

165,508.98
11,461.96
257,506.95

-62%

523,927.41
45,192.89
396,178.57
(8,530.71)
31,845.33
10,607.14
44,638.38
4,098.22
(3,311.88)
197,544.65
(7,740.00)
287,600.89
368,169.82
474,768.75
2,364,989.46

377,276.81

101,785.71
812,295.49
185,955.95
30,364.10
7,728.00
3,648.27
326,069.99
32,162.68
6,402.36
3,260.25
3,472.99
15,064.03

115%
100%
-100%
-12%
-100%
-100%
-100%
-100%
-76%
-100%
-100%
-100%
100%
100%
100%

13,581.24
723,654.49
2,699,923.44

100%
100%
100%
-100%
-91%
32%

742,115.07

39%
100%
100%
-106%
100%
-94%
-4%
#DIV/0!
-100%

51,915.68
645,012.76

-100%
-69%

421,525.42

100%
100%
100%

144,904.79
3,412.28
173,950.68
46,374.99

(25,653.22)
62,089.29
2,642,924.55

-100%
-11%

JUNE
29,874.12

70,210.86

27,566.97

127,651.95

1ST SEM
SALES
(17,061.43)
36,503.59
36,804.47
32,763.40
70,210.86
10,714.29
27,566.97
489,158.63
686,660.78

JULY

AUGUST

SEPTEMBER
15,625.00

28,917.87

14,869.19
152,550.00
80,461.25

37,897.31

66,815.18

75,798.32

26,696.43

233,011.25

132,988.94

3RD QTR
SALES
15,625.00
43,787.06
152,550.00
156,259.57
64,593.74
432,815.37

OCTOBER

NOVEMBER

74,554.47
20,643.75
7,921.88
94,950.00
76,201.08

2,961.61

182,282.79

DECEMBER

3,403.13
896,895.53
58,883.93

41,620.54

14,558.78
151,129.32

959,182.59

4TH QTR
SALES
74,554.47
20,643.75
11,325.01
991,845.53
135,085.01
44,582.15
14,558.78
1,292,594.70

YTD
(17,061.43)
126,683.06
57,448.22
87,875.47
1,144,395.53
361,555.44
10,714.29
109,175.89
27,566.97
489,158.63
14,558.78
2,412,070.85

LYTD
191,625.28
64,483.09
452,298.22

24,194.54
191,159.61
654,887.71
26,408.73
81,574.29
637,773.74
12,933.04
33,913.40
3,683.04
70,708.59
450,490.93
2,896,134.21

%GWT
-109%
96%
-87%
100%
100%
1394%
-100%
-98%
-100%
-100%
-100%
744%
#DIV/0!
-100%
-100%
-100%
100%
-97%
-17%

JUNE
799,417.88

(160.71)
479,776.79
479,616.08

6,951.79

1ST SEM
SALES
3,949,025.03
85,928.58
8,884.77
1,872.77
5,668.31
1,366,462.22
1,468,816.65

JULY

AUGUST

53,154.21

320,315.88

5,892.86
122.06
6,014.92

63,214.28
350,596.42
28,571.43
(109,375.00)
112,475.12
130,669.66
353.57

SEPTEMBER
547,209.82

1,781.25

1,781.25
106,589.29

24,553.57

75,892.86
28,940.89

21,205.35
28,157.14

204,642.86
86,089.29
912.51

291,644.66

80,258.92
656,764.40
848,732.15
789,677.22
(15,487.50)
912.51
1,625.00
23,276.79
(20,400.00)
144,125.67
50,982.14
1,823,443.98

46,428.57

53,494.46

182,482.15

122,321.43
177,142.85

247,321.43
73,214.28

710.72
1,285.71

47,139.29

(33,928.57)

42,410.71

266,821.42

362,946.42

3RD QTR
SALES

OCTOBER

NOVEMBER

920,679.91
7,674.11
122.06
7,796.17

898,843.05

235,930.52
251,948.38

6,857.15

19,856.61

106,589.29
24,553.57
75,892.86
28,940.89
235,976.61

58,500.00

109,678.57

49,500.00
28,445.53
138,392.85

416,071.43
250,357.13
710.72
1,285.71
8,482.14
676,907.13

581,044.89

DECEMBER
583,828.91

3,838.75

16,017.86

6,857.15

170,535.71

111,383.94

30,169.64

16,017.86

(4,241.08)

11,518.11
(41,071.43)
299,348.22

151,366.32

158,928.57
56,026.79

84,062.50
42,410.71

243,839.29

814.30
131,776.79

236,526.78

108,035.71

212,097.30

59,821.43

347,546.45

422,821.42

351,875.00

4TH QTR
SALES
2,063,716.85
3,838.75
38,892.87
235,930.52
278,662.14
217,678.57
28,445.53
308,928.56
137,312.50
11,518.11
(41,071.43)
662,811.84
242,991.07
342,276.79
814.30
476,339.28
59,821.43
1,122,242.87

YTD
6,933,421.79
85,928.58
12,723.52
1,872.77
52,235.29
1,602,514.80
1,755,274.96
387,482.14
28,445.53
684,078.55
28,571.43
(109,375.00)
112,475.12
343,875.02
353.57
28,940.89
11,518.11
39,187.49
1,555,552.85
1,507,794.65
1,382,311.14
(15,487.50)
2,437.53
479,249.99
23,276.79
(20,400.00)
212,429.24
50,982.14
3,622,593.98

LYTD

%GWT

7,437,083.73

-7%

1,785.71
83,169.64
128,152.43
58,416.08
247,918.40

639,862.80

-100%
3%
-90%
-100%
-99%
-22%
-100%
100%
174%

955,208.02

-59%

237,139.30
158,788.05
35,909.82

188%
100%
-405%
100%
100%
100%
100%

66,849.11
53,571.43

220,991.06
9,495.98
(82,654.50)
9,545.54
1,240,878.54
2,785,301.81
211,731.78
632,704.84
1,472,745.89
(12,857.15)
197,750.00
3,879.47
126,305.54
38,475.43
148,083.21
410,165.53
3,381.00
779,553.58
4,011,919.12

-97%
-44%
-100%
138%
-6%
20%
100%
142%
-100%
-100%
-40%
-114%
100%
-93%
-10%

1ST SEM
SALES

JUNE
1,093,790.16

217,221.43
217,221.43

32,908.93

661,531.25

4,122,235.81
221,265.11
47,899.22
1,210,761.22
1,479,925.55
(3,571.43)
62,195.48
102,857.14
19,932.14
(1,410.37)
37,485.72
217,488.68
30,357.14
32,908.93
3,467.53
680,369.21
892,223.65

JULY
790,526.49

AUGUST
242,661.26

SEPTEMBER
779,516.64

10,714.29
45,592.85
63,303.21
(956.46)
44,636.39

63,303.21

10,714.29

25,446.43
14,732.15
71,428.57

83,580.36

109,026.79

11,666.07

11,666.07

86,160.72

29,830.36
30,696.43

56,721.00
266,461.61

377,145.54
67,266.07

3RD QTR
SALES
1,812,704.39
10,714.29
45,592.85
63,303.21
(956.46)
118,653.89
25,446.43
14,732.15
71,428.57
95,246.43
206,853.58
29,830.36
30,696.43
433,866.54
333,727.68

OCTOBER
419,048.66

NOVEMBER
208,128.91

DECEMBER
672,548.19

(10,476.72)
(15,732.32)
14,508.93
4,929.29
17,857.14

33,482.15

10,626.79
24,553.57

10,626.79

35,639.89

75,892.85

109,375.00

35,044.64
154,098.21

42,125.00
35,044.64
516,205.80

39,000.00

236,201.34

83,695.53

40,178.58

3,125.00

125,906.25

(10,476.72)
(15,732.32)
47,991.08
4,929.29
17,857.14
10,626.79
100,446.42
155,641.68

83,695.53

4,464.29
35,714.29

34,642.82

1,299,725.76

642.82
21,428.57
4,464.29
35,714.29
92,508.03
3,758.93
158,516.93

642.82
21,428.57

8,812.50
3,758.93

4TH QTR
SALES

YTD
7,234,665.96
(10,476.72)
205,532.79
47,991.08
4,929.29
17,857.14
10,714.29
56,219.64
111,202.43
100,446.42
1,209,804.76
1,754,221.12
(3,571.43)
62,838.30
149,732.14
19,196.44
107,142.86
19,932.14
(1,410.37)
225,240.18
3,758.93
582,859.19
102,312.50
63,605.36
3,467.53
1,149,280.39
1,742,157.13

LYTD
13,643,049.50
6,698.71
(184,175.95)
77,640.24
46,292.50
966,921.26
130,203.68

%GWT
-47%
-100%
-100%
-113%
-100%
-79%
-100%

#DIV/0!
100%
100%
3,926,698.12
6,181.21
4,976,459.77

-69%
-100%
-65%

416,139.44
116,190.05
34,526.78
591,941.52

-101%
-46%
100%
-100%
#DIV/0!
#DIV/0!
100%

(370,598.44)
100%
12,491.06
76,903.55
877,593.96
133,475.90
138,649.52
218,684.26
16,653.51
74,911.32
110,496.08
31,413.71
1,278,410.72
1,865,778.73

-100%
-34%
-100%
-100%
-53%
100%
-100%
100%
100%
-7%

JUNE
694,440.18
167,454.46
(6,080.36)

20,754.45

182,128.55

1ST SEM
SALES

JULY

AUGUST

SEPTEMBER

3RD QTR
SALES

OCTOBER

NOVEMBER

DECEMBER

4TH QTR
SALES

YTD

LYTD

%GWT

1,639,326.46

323,182.61

97,962.50

406,975.90

828,121.01

275,201.34

129,031.25

189,142.85

593,375.44

3,060,822.91

3,868,473.75

-21%

612,970.53
2,830.36
6,450.89
79,446.41
16,708.84
5,258.71
34,320.36
27,509.02
785,495.12
-

294,908.02
2,026.79

61,622.33
8,107.15

80,821.44

437,351.79
10,133.94
6,392.86
4,053.57
22,616.07
19,398.22
155,892.86
3,236.60
659,075.91
-

92,497.35
6,080.36

34,422.31
29,191.96
8,285.71

150,629.45

277,549.11
35,272.32
8,285.71
6,080.36
103,616.08
18,321.43
122,544.64
(182,656.51)
3,178.57
392,191.71
28,445.53

1,327,871.43
48,236.62
14,736.60
12,473.22
83,499.98
126,232.15
54,428.49
155,892.86
122,544.64
(182,656.51)
5,258.71
34,320.36
33,924.19
1,836,762.74
28,445.53

1,746,405.29
37,894.65

-24%
27%
100%
100%
100%
#DIV/0!
-58%
#DIV/0!

6,392.86
4,053.57
22,616.07
12,281.79
155,892.86

7,116.43

3,236.60
313,680.70

69,729.48

275,665.73

6,080.36
63,348.22
18,321.43

40,267.86

32,366.07

90,178.57

(182,656.51)

98,577.71

3,279.19

3,178.57
290,334.81
28,445.53

670,502.68
129,960.84

15,505.24

-100%

54,599.52
201,447.77
11,769.18
1,049,285.07
3,151.78
3,920,522.02

-100%
100%
-97%
976%
-53%
#DIV/0!

% Perf

40%

% Perf
49%

52%

42%

% Perf
48%

49%

57%

% Perf
51%

66%

#DIV/0!

40%

% Perf

49%

% Perf
37%

35%

26%

46%

% Perf
23%

#DIV/0!

18%

#DIV/0!
#DIV/0!

8%

% Perf
38%

#DIV/0!
#DIV/0!

28%
#DIV/0!